There are a few conditions that would make a medication unsafe for a patient to take, when it comes to GLP-1s and GLP/GIP medications
heart failure risk - An FDA warning (4/6/16) was added to saxagliptin regarding an increased risk of heart failure observed in two randomized trials (3.5% risk vs 2.8% for those taking placebo)
Identical and they can be interchanged
Forbes JM, Sourris KC, de Courten MPJ, et al
Understanding this flexibility window, along with the risks of improper timing adjustments, helps you maintain safe, effective treatment while accommodating real-world scheduling needs
If you accidentally shook it once, let the solution settle, check for persistent foam or cloudiness, and proceed with caution